PowerCHO® 2 Serum-free Medium is CD with HEPES, Pluronic® F-68, without L-Glutamine, Phenol red, hypoxanthine or thymidine, 1L
PowerCHO® 2 Powder Kit 10L, chemically defined, with HEPES, Pluronic® F-68, without L-glutamine, phenol red, hypoxanthine or thymidine
PowerCHO® 1 Basal Powder with HEPES, Pluronic® F-68, without L-glutamine, phenol red, hypoxanthine or thymidine, 50L
PowerCHO® 2 Basal Powder, 100 L, chemically defined
PowerCHO® 2 Powder Kit 50 L, chemically defined, with HEPES, Pluronic® F-68, without L-glutamine, phenol red, hypoxanthine or thymidine
PowerCHO® 2 Powder Kit 500 L, chemically defined, with HEPES, Pluronic® F-68, without L-glutamine, phenol red, hypoxanthine or thymidine
PowerCHO® 2 Powder kit 100 L, with HEPES, Pluronic® F-68, without L-Glutamine, Phenol red, hypoxanthine or thymidine
PowerCHO® 1 Powder kit, with HEPES, Pluronic® F-68, without L-Glutamin, Phenol red, hypoxanthine or thymidine, 50L
Chemically defined, non-animal origin (NAO), serum-free medium
UltraDOMA® Protein-free Medium, chemically defined, Hybridoma medium, with L-Glutamine, 500 mL
-
References - X-Vivo™Overview of relevant references
-
Instructions for Use – TheraPEAK® X-VIVO® Cell Culture MediumInstructions for how to use the X-VIVO® Media Series
-
A Novel In Vitro Liver Cell Culture Flow System Allowing Long-Term Metabolism and Hepatotoxicity Studies]Manuscript published in Applied In Vitro Toxicology journal describes improvement of CYP450 phenotype of primary cryopreserved hepatocytes using Quasi Vivo® System
-
TheraPEAK® X-VIVO® Hematopoietic Cell Culture MediumSerum-free, GMP produced medium for cell therapy applications
-
Formulation - Leibovitz Modified Medium (L-15)Composition of L-15 (12-669)
-
Primary Normal Human Cells and MediaIn Vivo Relevance. In Vitro Results. Updated and revised cell content.
-
A Non-Viral Method for Modifying and Expanding Primary T CellsLearn how Lonza’s Cocoon® Platform, 4D-Nucleofector® LV Unit and X-VIVO® 15 Medium are integrated to enable non-viral genetic modification and subsequent expansion of primary T cells in a functionally-closed, automated workflow.
-
Formulation - Leibovitz Medium (L-15)Components present in L-15 (12-700).
-
TechSheet – L-15 Leibovitz MediumHow to use L-15 Medium
-
Building Better In Vitro Models Using the Quasi Vivo® SystemOverview webinar providing details and application data using the Quasi Vivo® Systems delivered by Dr. Kelly Davidge, Scientist at Kirkstall Inc.